Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
NextCure Inc (NXTC)
NASDAQ:NXTC
NextCure (NXTC) Stock Price & Analysis
256 Followers
NXTC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.16 - $5.27
Previous Close$1.72
Volume20.17K
Average Volume (3M)65.54K
Market Cap
$47.88M
Enterprise Value$139.87M
Total Cash (Recent Filing)$29.97M
Total Debt (Recent Filing)$121.97M
Price to Earnings (P/E)-0.7
Beta0.76
Next Earnings
Aug 03, 2023EPS Estimate
-$0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.53
Shares Outstanding27,834,911
10 Day Avg. Volume59,015
30 Day Avg. Volume65,539
Standard Deviation0.24
R-Squared0.00022
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.33
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.08
Forecast
1Y Price Target
$6.00Price Target Upside242.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
NextCure News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NXTC FAQ
What was NextCure Inc’s price range in the past 12 months?
NextCure Inc lowest stock price was $1.16 and its highest was $5.27 in the past 12 months.
What is NextCure Inc’s market cap?
Currently, no data Available
When is NextCure Inc’s upcoming earnings report date?
NextCure Inc’s upcoming earnings report date is Aug 03, 2023 which is in 64 days.
How were NextCure Inc’s earnings last quarter?
NextCure Inc released its earnings results on May 04, 2023. The company reported -$0.58 earnings per share for the quarter, beating the consensus estimate of -$0.62 by $0.04.
Is NextCure Inc overvalued?
According to Wall Street analysts NextCure Inc’s price is currently Undervalued.
Does NextCure Inc pay dividends?
NextCure Inc does not currently pay dividends.
What is NextCure Inc’s EPS estimate?
NextCure Inc’s EPS estimate is -$0.55.
How many shares outstanding does NextCure Inc have?
NextCure Inc has 27,834,911 shares outstanding.
What happened to NextCure Inc’s price movement after its last earnings report?
NextCure Inc reported an EPS of -$0.58 in its last earnings report, beating expectations of -$0.62. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of NextCure Inc?
Among the largest hedge funds holding NextCure Inc’s share is Harbourvest Partners Llc. It holds NextCure Inc’s shares valued at 15K.
---
NextCure Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.61%
12-Months-Change
Fundamentals
Return on Equity
-38.15%
Trailing 12-Months
Asset Growth
-24.67%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
NextCure Inc
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lieping Chen in September 2015 and is headquartered in Beltsville, MD.
---
Top 5 ETFs holding NXTC
iShares Core S&P Total U.S. Stock Market ETF
$34.62K
Up to five ETFs with an Outperform Smart Score that hold NXTC. The ETFs are listed according to market value of NXTC within the ETF
---
---